(+/-)-3,4-DIHYDRO-5,12-DIMETHOXY-2,2-DIMETHYL-4-HYDROXY-2H-ANTHRA-[2,3-B]-PYRAN-6,11-DIONE
Compound with spectra: 1 NMR
![(+/-)-3,4-DIHYDRO-5,12-DIMETHOXY-2,2-DIMETHYL-4-HYDROXY-2H-ANTHRA-[2,3-B]-PYRAN-6,11-DIONE](/api/compound/6fmZRvcZDjE.png?ph=true&h=300&w=458 "(+/-)-3,4-DIHYDRO-5,12-DIMETHOXY-2,2-DIMETHYL-4-HYDROXY-2H-ANTHRA-[2,3-B]-PYRAN-6,11-DIONE")
| SpectraBase Compound ID | 6fmZRvcZDjE |
|---|---|
| InChI | InChI=1S/C21H20O6/c1-21(2)9-12(22)13-18(25-3)14-15(19(26-4)20(13)27-21)17(24)11-8-6-5-7-10(11)16(14)23/h5-8,12,22H,9H2,1-4H3/t12-/m1/s1 |
| InChIKey | WNGJKWCTPBMRMN-GFCCVEGCSA-N |
| Mol Weight | 368.39 g/mol |
| Molecular Formula | C21H20O6 |
| Exact Mass | 368.125988 g/mol |
| Enantiomer InChIKey | WNGJKWCTPBMRMN-LBPRGKRZSA-N |
| Racemate InChIKey | WNGJKWCTPBMRMN-UHFFFAOYSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(+/-)-7,11-DIHYDROXY-6-METHOXY-9-METHYLIDENE-7,8,9,10-TETRAHYDRONAPHTHACENE-5,12-DIONE
1,3-dimethoxy-2-(6-methyltetrahydro-2H-pyran-2-yl)anthraquinone
1,5-dihydroxy-12-methoxy-3,3-dimethyl-3,4-dihydro-1H-anthra[2,3-c]pyran-6,11-dione
2-(1',2'-DIHYDROXYPROPYL)-1,4-DIMETHOXY-3-(2''-METHYLPROP-2''-ENYL)-ANTHRAQUINONE
(4'R,6'R)-2-(4',6'-dimethyl-1',3'-dioxan-2'-yl)-1,4-dimethoxy-3-(2''-methylprop-2''-enyloxy)anthraquinone
(4'R,6'R)-2-(4',6'-DIMETHYL-1',3'-DIOXAN-2'-YL)-1,4-DIMETHOXY-3-(2''-METHYLPROP-2''-ENYL)-ANTHRAQUINONE
1H-Cyclopent[b]anthracene-5,10-dione, 1-acetyl-2,3-dihydro-4,11-dimethoxy-
8-Acetyl-8-[(ethoxycarbonyl)oxy]-7,8,9,10-tetrahydro-6,11-dimethoxy-5,12-naphthacenedione
ANTHRAGALLOL-1-METHYLETHER-3-O-RUTINOSIDE
2-[(4R,6R)-4,6-dimethyl-1,3-dioxan-2-yl]-1-methoxy-3-(2-methylprop-2-enyl)-4-oxidanyl-anthracene-9,10-dione
| Title | Journal or Book | Year |
|---|---|---|
| 2,2-Dimethyl-2H-anthra[2,3-b]pyran-6,11-diones: a new class of cytotoxic compounds | Bioorganic & Medicinal Chemistry | 2001 |